Editas Medicine CFO Sells Small Stake to Cover RSU Tax Bill
Amy Parison, senior vice president and chief financial officer of Editas Medicine, sold 474 shares of the company’s common stock on March 3, 2026, under a pre-arranged automatic sales plan established in 2022 to meet tax obligations arising from restricted stock units that vested on March 2, 2026. The trade, reported on a Form 4 filing, totaled $95…